CPT 81426: Familial Whole Genome Reference Sequence
Commercial payers pay $2238 on average nationally for this procedure.
CPT code 81426 describes laboratory analysis in which a gene sequence of an entire genome from a relative is generated as a reference to compare against the patient’s genome to evaluate an unexplained disorder or syndrome; service type: whole genome sequencing of a familial reference sample, typical site of service: clinical molecular genetics laboratory or reference laboratory.
For related coverage guidance, see recent payer policy updates: Minimal Residual Disease (MRD) Testing for Cancer, Biomarker Testing Mandate, Prenatal (Fetal) Diagnostic Testing.
Customize your policy alerts
Sign up for cpt 81426 policy alerts
Get alerted when payer policies referencing 81426 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
BUCA (average commercial) sits near the center of the national commercial distribution for CPT 81426 with a mean of $2,238.40 and an interquartile spread from $1,352.80 to $2,694.10. Blue Cross Blue Shield and Cigna both show higher central tendencies—BCBS mean $2,784 and Cigna mean $2,652.30—while UnitedHealth Group’s mean of $2,160.70 is slightly below BUCA. Aetna’s mean of $265.60 is an outlier on the low side and is driven by a heavily skewed distribution.
Comparing dispersion using P75 minus P25 highlights variability: Blue Cross Blue Shield has a spread of $1,428.90 ($3,291.80 − $1,862.90) and Cigna a spread of $2,189.60 ($3,579.40 − $1,389.80), indicating wider variability for Cigna. UnitedHealth Group’s interquartile spread is $1,571.70 ($2,709.90 − $1,138.20), while BUCA’s IQR is $1,341.30 ($2,694.10 − $1,352.80). Aetna’s quartiles are both $0, implying an IQR of $0 and the tightest distribution among the listed payers.